ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,249, issued on Dec. 2, was assigned to Eli Lilly & Co. (Indianapolis).
"SSTR4 agonist salts" was invented by David Andrew Coates (New Palestine, Ind.) and David Michael Remick (Fishers, Ind.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to specific salts of (1S,5R)-(1Alpha,5Alpha,6Alpha)-N-[1,1-dimethyl-2-[(3-methyl-2-pyridyl)oxy]ethyl]-3-azabicyclo[3.1.0]hexane-6-carboxamide, to pharmaceutical compositions comprising said salts, to methods of using said salts to treat physiological disorders, and to intermediates useful in the synthesis of the salts."
The patent was filed on Aug. 7, 2023, under Application No. 18/366,...